Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via “Antigen Capsid-Incorporation” strategy

Adenoviral (Ad) vectors in combination with the “Antigen Capsid-Incorporation” strategy have been applied in developing HIV-1 vaccines, due to the vectors’ abilities in incorporating and inducing immunity of capsid-incorporated antigens. Variable loop 2 (V2)-specific antibodies were suggested in the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Virology
Main Authors: Gu, Linlin, Krendelchtchikova, Valentina, Krendelchtchikov, Alexandre, Farrow, Anitra L., Derdeyn, Cynthia A., Matthews, Qiana L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4769379/
https://ncbi.nlm.nih.gov/pubmed/26499044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2015.10.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados